News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dongcheng Biochemicals Stages $110 Million IPO in Shenzhen



5/29/2012 8:39:10 AM

by Richard Daverman, PhD

May 25, 2012 -- Yantai Dongcheng Biochemicals has completed a $110 million IPO on Shenzhen’s Small and Medium-Sized Enterprises Board. The main products from Dongcheng Biochemicals, which makes APIs and finished products, are heparin sodium and chondroitin sulphate, a dietary supplement that treats osteoarthritis. More details....

Stock Symbol: (SHE: 002675)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES